Uptake of tumour necrosis factor – alpha inhibitor biosimilars for psoriasis: A drug utilisation study from BADBIR
BJD, 2023.
Phan DB, Bewley AP, Smith CH, Mackenzie T, Griffiths CEM, Lunt M, Warren RB, Yiu ZZN; BADBIR Study Group.
Read publication: BJD
Related
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoria...
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
0 Comments